SUSAN BRAZIL: Open Payments
NPI 1538263959 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 28 payments from 14 companies in 2025. Trend: 2023 $428 · 2024 $916 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| CVRx, Inc. | 4 | $90 |
| Amgen Inc. | 5 | $80 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| Edwards Lifesciences Corporation | 1 | $60 |
| PFIZER INC. | 2 | $37 |
| Abbott Laboratories | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $22 |
Products named: LEQVIO, Barostim Neo System, REPATHA, VERQUVO, PASCAL, VYNDAQEL, AMPLATZER, Kerendia.
Industry payments across FL — which companies pay providers there.
